Itamar Averbuch

4PUBLICATIONS
8CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 15, 2025
Planning Target Volume and Nodal Status Predict Clinical Outcomes After Chemoradiation and Durvalumab in Stage III Non-Small Cell Lung Cancer.

Ori Aslan, Johnathan Arnon, Itamar Averbuch

|May 06, 2024
Assessing the effect of metastasis-directed therapy in oligometastatic disease using the restricted mean survival time.

Itamar Averbuch, Assaf Moore, Ethan B Ludmir

|Apr 24, 2023
Correlations between pathogenic variants in DNA repair genes and anticancer treatment efficacy in stage IV non-small cell lung cancer: A large real-world cohort and review of the literature.

Itamar Averbuch, Roi Tschernichovsky, Oded Icht

|Apr 03, 2023
Avelumab for the treatment of locally advanced or metastatic Merkel cell carcinoma-A multicenter real-world experience in Israel.

Itamar Averbuch, Ronen Stoff, Mor Miodovnik

Pageof 1

Frequent Collaborators

1 joint publications

Nethanel Asher

1 joint publications

Eyal Fenig

1 joint publications

Ethan B Ludmir

1 joint publications

Ori Aslan